| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.92M | 14.77M | 15.24M | 14.72M | 14.02M | 11.54M |
| Gross Profit | 6.96M | 6.84M | 6.94M | 6.77M | 7.04M | 4.97M |
| EBITDA | 2.06M | 1.93M | 1.58M | 1.70M | 2.57M | 1.20M |
| Net Income | 1.02M | 888.00K | 768.00K | 931.00K | 1.47M | 393.00K |
Balance Sheet | ||||||
| Total Assets | 15.23M | 15.27M | 15.01M | 14.21M | 14.70M | 13.84M |
| Cash, Cash Equivalents and Short-Term Investments | 2.62M | 2.17M | 1.68M | 2.72M | 4.41M | 3.68M |
| Total Debt | 171.00K | 202.00K | 85.00K | 118.00K | 191.00K | 55.00K |
| Total Liabilities | 2.71M | 2.96M | 2.83M | 3.02M | 7.02M | 8.22M |
| Stockholders Equity | 12.52M | 12.30M | 12.18M | 11.19M | 7.68M | 5.62M |
Cash Flow | ||||||
| Free Cash Flow | 1.08M | 800.00K | -713.00K | -1.29M | 1.05M | 683.00K |
| Operating Cash Flow | 1.57M | 1.58M | 137.00K | 233.00K | 1.80M | 931.00K |
| Investing Cash Flow | -446.00K | -670.00K | -849.00K | -1.45M | -727.00K | -206.00K |
| Financing Cash Flow | -408.00K | -407.00K | -376.00K | -389.00K | -360.00K | -59.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £285.14M | 22.53 | 10.01% | 3.48% | -3.93% | 41.83% | |
74 Outperform | £8.62M | 8.46 | 8.12% | 3.84% | -0.57% | 32.71% | |
70 Neutral | £129.25M | 17.49 | 7.23% | 3.97% | 5.51% | -33.75% | |
66 Neutral | £91.22M | 9.83 | 25.06% | 4.63% | 12.60% | 6.64% | |
65 Neutral | £175.11M | 34.72 | 9.50% | 4.39% | -3.51% | -67.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | £10.97M | -3.40 | -11.61% | ― | -27.62% | -228.90% |
Samuel Heath & Sons PLC reported a modest increase in sales and operating profit for the first half of 2025, despite challenges such as increased national insurance contributions and tariffs on US sales. The company is facing a tougher economic environment in its key markets, leading to reduced headcount and cost-cutting measures in anticipation of weaker sales in the second half of the year. New product finishes have been well-received, and a collaboration with designer Laura Hammett is expected to boost future sales.
The most recent analyst rating on (GB:HSM) stock is a Buy with a £374.00 price target. To see the full list of analyst forecasts on Heath (Samuel) & Sons stock, see the GB:HSM Stock Forecast page.